Dr. Mouhamed Yazan Abou-Ismail, M.D
NPI: 1336553676
Total Payments
$12,972
2024 Payments
$4,706
Companies
15
Transactions
35
Medicare Patients
374
Medicare Billing
$57,665
Payment Breakdown by Category
Consulting$10,349 (79.8%)
Food & Beverage$1,808 (13.9%)
Other$750.00 (5.8%)
Travel$64.74 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,349 | 3 | 79.8% |
| Food and Beverage | $1,808 | 30 | 13.9% |
| Grant | $750.00 | 1 | 5.8% |
| Travel and Lodging | $64.74 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $9,467 | 17 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,124 | 2 | $0 (2024) |
| Novo Nordisk Inc | $750.00 | 1 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $128.46 | 1 | $0 (2021) |
| Genentech, Inc. | $121.71 | 1 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $90.57 | 2 | $0 (2022) |
| Genentech USA, Inc. | $67.21 | 1 | $0 (2024) |
| Eisai Inc. | $60.00 | 1 | $0 (2024) |
| Incyte Corporation | $41.23 | 2 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.38 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,706 | 7 | GENZYME CORPORATION ($2,470) |
| 2023 | $571.39 | 6 | GENZYME CORPORATION ($449.68) |
| 2022 | $6,424 | 6 | GENZYME CORPORATION ($6,345) |
| 2021 | $273.72 | 3 | GENZYME CORPORATION ($145.26) |
| 2020 | $134.28 | 5 | GENZYME CORPORATION ($57.07) |
| 2019 | $811.49 | 5 | Novo Nordisk Inc ($750.00) |
| 2018 | $51.35 | 3 | Incyte Corporation ($19.87) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/19/2024 | Eisai Inc. | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 06/24/2024 | Genentech USA, Inc. | Hemlibra (Biological) | Food and Beverage | In-kind items and services | $67.21 | General |
| Category: Hematology | ||||||
| 05/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,109.00 | General |
| 04/16/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 04/16/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $127.56 | General |
| 03/05/2024 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $93.03 | General |
| Category: Hematology | ||||||
| 01/13/2024 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $108.93 | General |
| Category: Hematology | ||||||
| 12/11/2023 | GENZYME CORPORATION | ENJAYMO (Biological), CABLIVI | Food and Beverage | In-kind items and services | $145.88 | General |
| Category: Hematology | ||||||
| 12/10/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $25.56 | General |
| 06/26/2023 | GENZYME CORPORATION | CABLIVI (Biological), ENJAYMO | Food and Beverage | In-kind items and services | $101.05 | General |
| Category: Hematology | ||||||
| 06/25/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $88.04 | General |
| 05/24/2023 | GENZYME CORPORATION | ENJAYMO (Biological), CABLIVI | Food and Beverage | In-kind items and services | $89.15 | General |
| Category: Hematology | ||||||
| 04/18/2023 | Genentech, Inc. | Hemlibra (Biological) | Food and Beverage | In-kind items and services | $121.71 | General |
| Category: Hematology | ||||||
| 11/12/2022 | GENZYME CORPORATION | CABLIVI (Biological) | Consulting Fee | Cash or cash equivalent | $6,100.00 | General |
| Category: Hematology | ||||||
| 11/12/2022 | GENZYME CORPORATION | CABLIVI (Biological) | Travel and Lodging | Cash or cash equivalent | $64.74 | General |
| Category: Hematology | ||||||
| 09/27/2022 | GENZYME CORPORATION | ENJAYMO (Biological), CABLIVI | Food and Beverage | In-kind items and services | $89.86 | General |
| Category: Hematology | ||||||
| 04/25/2022 | GENZYME CORPORATION | ENJAYMO (Biological), CABLIVI | Food and Beverage | In-kind items and services | $70.82 | General |
| Category: Hematology | ||||||
| 04/19/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $79.00 | General |
| Category: Rare Disease | ||||||
| 03/09/2022 | GENZYME CORPORATION | CABLIVI (Biological), ENJAYMO | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Hematology | ||||||
| 12/12/2021 | SANOFI-AVENTIS U.S. LLC | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $128.46 | General |
| Category: Hematology | ||||||
| 09/20/2021 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $52.50 | General |
| Category: Hematology | ||||||
| 03/17/2021 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $92.76 | General |
| Category: Hematology | ||||||
| 12/23/2020 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $57.07 | General |
| Category: Hematology | ||||||
| 02/24/2020 | Ipsen Biopharmaceuticals, Inc | SOMATULINE DEPOT (Drug), ONIVYDE | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Oncology/Endocrinology | ||||||
| 02/10/2020 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 112 | 137 | $43,683 | $14,734 |
| 2022 | 5 | 114 | 161 | $49,236 | $17,036 |
| 2021 | 5 | 100 | 136 | $41,124 | $14,960 |
| 2020 | 2 | 48 | 111 | $28,221 | $10,936 |
Total Patients
374
Total Services
545
Medicare Billing
$57,665
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 36 | $15,988 | $4,888 | 30.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 43 | $9,752 | $4,005 | 41.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 14 | 18 | $5,695 | $1,838 | 32.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $4,965 | $1,704 | 34.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $5,593 | $1,617 | 28.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 11 | $1,690 | $681.12 | 40.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 39 | 41 | $17,335 | $6,319 | 36.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 33 | 72 | $15,556 | $5,754 | 37.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 15 | 21 | $6,273 | $2,099 | 33.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 16 | 16 | $6,889 | $1,841 | 26.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $3,182 | $1,023 | 32.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 32 | 32 | $13,347 | $4,806 | 36.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 22 | 54 | $11,555 | $4,319 | 37.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 15 | 19 | $5,559 | $2,148 | 38.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 19 | 19 | $5,496 | $2,000 | 36.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 12 | 12 | $5,167 | $1,687 | 32.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 26 | 89 | $19,045 | $7,389 | 38.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 22 | 22 | $9,176 | $3,547 | 38.7% |
About Dr. Mouhamed Yazan Abou-Ismail, M.D
Dr. Mouhamed Yazan Abou-Ismail, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2014. The National Provider Identifier (NPI) number assigned to this provider is 1336553676.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mouhamed Yazan Abou-Ismail, M.D has received a total of $12,972 in payments from pharmaceutical and medical device companies, with $4,706 received in 2024. These payments were reported across 35 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($10,349).
As a Medicare-enrolled provider, Abou-Ismail has provided services to 374 Medicare beneficiaries, totaling 545 services with total Medicare billing of $57,665. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Hematology & Oncology
- Location Rochester, NY
- Active Since 06/14/2014
- Last Updated 10/15/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1336553676
Products in Payments
- CABLIVI (Biological) $6,818
- ENJAYMO (Biological) $395.71
- Hemlibra (Biological) $188.92
- ULTOMIRIS (Biological) $79.00
- JAKAFI (Drug) $41.23
- GILOTRIF (Drug) $32.38
- SOMATULINE DEPOT (Drug) $22.90
- XPOVIO (Drug) $21.74
- NERLYNX (Drug) $19.29
- Doptelet (Drug) $13.28
- Imbruvica (Drug) $12.31
- Soliris (Drug) $11.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Rochester
Dr. Yucai Wang, Md, Phd, MD, PHD
Student in an Organized Health Care Education/Training Program — Payments: $1.1M
Student in an Organized Health Care Education/Training Program $1.1M
Kevin Perry, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $675,526
Student in an Organized Health Care Education/Training Program $675,526
Arjun Sebastian, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $132,513
Student in an Organized Health Care Education/Training Program $132,513
Benjamin Tracy
Student in an Organized Health Care Education/Training Program — Payments: $112,594
Student in an Organized Health Care Education/Training Program $112,594
Dr. Vijay Agarwal, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $105,512
Student in an Organized Health Care Education/Training Program $105,512
Mr. Timothy Brown, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $89,868
Student in an Organized Health Care Education/Training Program $89,868